1-2 of 2
Martin Wolf, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Activity of Abemaciclib (LY2835219), a Cell Cycle Inhibitor Selective for CDK4 and CDK6, in Patients with Relapsed or Refractory Mantle Cell Lymphoma

Free
Franck Morschhauser, MD PhD, Kamal Bouabdallah, MD, Stephan Stilgenbauer, MD, Catherine Thieblemont, MD PhD, Martin Wolf, MD, Sophie de Guibert, MD, Florian Zettl, MD, Marjo Hahka-Kemppinen, MD PhD, David Xiaohui Wang, MD PhD, Patrick Brueck, MD, Charles Caldwell, MD, Richard Beckmann, PhD, Lawrence Gelbert, PhD, Damien Cronier, PhD, Ji Lin, PhD, Lily Li, MD, Edward M. Chan, MD, Michael Pfreundschuh, Martin Wilhem, MD, Georg Hess, MD
Journal: Blood
Blood (2014) 124 (21): 3067.
https://doi.org/10.1182/blood.V124.21.3067.3067
Published: 2014
Journal Articles

Induction Treatment In Elderly Patients with Acute Myeloid Leukemia (AML): Randomized Comparison of Intermediate-Dose Cytarabine Plus Mitoxantrone (IMA) Versus Standard-Dose Cytarabine Plus Daunorubicin (DA) In 492 AML Patients >60 Years – Results From the SAL 60plus Trial

Free
Christoph Röllig, Michael Kramer, Mathias Hanel, MD, Regina Herbst, Norbert Schmitz, MD, Heinrich Bodenstein, Karl-Heinz Pflüger, Thomas Wagner, Martin Wolf, MD, Martin Bornhäuser, Christian Thiede, MD, Markus Schaich, MD, Uwe Platzbecker, Friedrich Stölzel, MD, Malte von Bonin, Hannes Wandt, MD, Gerhard Ehninger, Ulrich Schuler
Journal: Blood
Blood (2010) 116 (21): 334.
https://doi.org/10.1182/blood.V116.21.334.334
Published: 2010